Literature DB >> 20101243

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.

Gloria M Petersen1, Laufey Amundadottir, Charles S Fuchs, Peter Kraft, Rachael Z Stolzenberg-Solomon, Kevin B Jacobs, Alan A Arslan, H Bas Bueno-de-Mesquita, Steven Gallinger, Myron Gross, Kathy Helzlsouer, Elizabeth A Holly, Eric J Jacobs, Alison P Klein, Andrea LaCroix, Donghui Li, Margaret T Mandelson, Sara H Olson, Harvey A Risch, Wei Zheng, Demetrius Albanes, William R Bamlet, Christine D Berg, Marie-Christine Boutron-Ruault, Julie E Buring, Paige M Bracci, Federico Canzian, Sandra Clipp, Michelle Cotterchio, Mariza de Andrade, Eric J Duell, J Michael Gaziano, Edward L Giovannucci, Michael Goggins, Göran Hallmans, Susan E Hankinson, Manal Hassan, Barbara Howard, David J Hunter, Amy Hutchinson, Mazda Jenab, Rudolf Kaaks, Charles Kooperberg, Vittorio Krogh, Robert C Kurtz, Shannon M Lynch, Robert R McWilliams, Julie B Mendelsohn, Dominique S Michaud, Hemang Parikh, Alpa V Patel, Petra H M Peeters, Aleksandar Rajkovic, Elio Riboli, Laudina Rodriguez, Daniela Seminara, Xiao-Ou Shu, Gilles Thomas, Anne Tjønneland, Geoffrey S Tobias, Dimitrios Trichopoulos, Stephen K Van Den Eeden, Jarmo Virtamo, Jean Wactawski-Wende, Zhaoming Wang, Brian M Wolpin, Herbert Yu, Kai Yu, Anne Zeleniuch-Jacquotte, Joseph F Fraumeni, Robert N Hoover, Patricia Hartge, Stephen J Chanock.   

Abstract

We conducted a genome-wide association study of pancreatic cancer in 3,851 affected individuals (cases) and 3,934 unaffected controls drawn from 12 prospective cohort studies and 8 case-control studies. Based on a logistic regression model for genotype trend effect that was adjusted for study, age, sex, self-described ancestry and five principal components, we identified eight SNPs that map to three loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Two correlated SNPs, rs9543325 (P = 3.27 x 10(-11), per-allele odds ratio (OR) 1.26, 95% CI 1.18-1.35) and rs9564966 (P = 5.86 x 10(-8), per-allele OR 1.21, 95% CI 1.13-1.30), map to a nongenic region on chromosome 13q22.1. Five SNPs on 1q32.1 map to NR5A2, and the strongest signal was at rs3790844 (P = 2.45 x 10(-10), per-allele OR 0.77, 95% CI 0.71-0.84). A single SNP, rs401681 (P = 3.66 x 10(-7), per-allele OR 1.19, 95% CI 1.11-1.27), maps to the CLPTM1L-TERT locus on 5p15.33, which is associated with multiple cancers. Our study has identified common susceptibility loci for pancreatic cancer that warrant follow-up studies.

Entities:  

Mesh:

Year:  2010        PMID: 20101243      PMCID: PMC2853179          DOI: 10.1038/ng.522

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  29 in total

1.  Sequential haplotype scan methods for association analysis.

Authors:  Zhaoxia Yu; Daniel J Schaid
Journal:  Genet Epidemiol       Date:  2007-09       Impact factor: 2.135

2.  Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia.

Authors:  Rodrigo T Calado; Joshua A Regal; Mark Hills; William T Yewdell; Leandro F Dalmazzo; Marco A Zago; Peter M Lansdorp; Donna Hogge; Stephen J Chanock; Elihu H Estey; Roberto P Falcão; Neal S Young
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-15       Impact factor: 11.205

Review 3.  Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases.

Authors:  Jin-Tang Dong; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

4.  New common variants affecting susceptibility to basal cell carcinoma.

Authors:  Simon N Stacey; Patrick Sulem; Gisli Masson; Sigurjon A Gudjonsson; Gudmar Thorleifsson; Margret Jakobsdottir; Asgeir Sigurdsson; Daniel F Gudbjartsson; Bardur Sigurgeirsson; Kristrun R Benediktsdottir; Kristin Thorisdottir; Rafn Ragnarsson; Dominique Scherer; Kari Hemminki; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Rafael Botella-Estrada; Virtudes Soriano; Pablo Juberias; Berta Saez; Yolanda Gilaberte; Victoria Fuentelsaz; Cristina Corredera; Matilde Grasa; Veronica Höiom; Annika Lindblom; Johannes J Bonenkamp; Michelle M van Rossum; Katja K H Aben; Esther de Vries; Mario Santinami; Maria G Di Mauro; Andrea Maurichi; Judith Wendt; Pia Hochleitner; Hubert Pehamberger; Julius Gudmundsson; Droplaug N Magnusdottir; Solveig Gretarsdottir; Hilma Holm; Valgerdur Steinthorsdottir; Michael L Frigge; Thorarinn Blondal; Jona Saemundsdottir; Hjördis Bjarnason; Kristleifur Kristjansson; Gyda Bjornsdottir; Ichiro Okamoto; Licia Rivoltini; Monica Rodolfo; Lambertus A Kiemeney; Johan Hansson; Eduardo Nagore; José I Mayordomo; Rajiv Kumar; Margaret R Karagas; Heather H Nelson; Jeffrey R Gulcher; Thorunn Rafnar; Unnur Thorsteinsdottir; Jon H Olafsson; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

5.  Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.

Authors:  Siân Jones; Ralph H Hruban; Mihoko Kamiyama; Michael Borges; Xiaosong Zhang; D Williams Parsons; Jimmy Cheng-Ho Lin; Emily Palmisano; Kieran Brune; Elizabeth M Jaffee; Christine A Iacobuzio-Donahue; Anirban Maitra; Giovanni Parmigiani; Scott E Kern; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; James R Eshleman; Michael Goggins; Alison P Klein
Journal:  Science       Date:  2009-03-05       Impact factor: 47.728

Review 6.  Familial pancreatic cancer.

Authors:  Chanjuan Shi; Ralph H Hruban; Alison P Klein
Journal:  Arch Pathol Lab Med       Date:  2009-03       Impact factor: 5.534

7.  Dyskeratosis congenita.

Authors:  Sharon A Savage; Blanche P Alter
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

Review 8.  Liver receptor homolog-1, an emerging metabolic modulator.

Authors:  Yoon-Kwang Lee; David D Moore
Journal:  Front Biosci       Date:  2008-05-01

9.  Lung cancer susceptibility locus at 5p15.33.

Authors:  James D McKay; Rayjean J Hung; Valerie Gaborieau; Paolo Boffetta; Amelie Chabrier; Graham Byrnes; David Zaridze; Anush Mukeria; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; John McLaughlin; Frances Shepherd; Alexandre Montpetit; Steven Narod; Hans E Krokan; Frank Skorpen; Maiken Bratt Elvestad; Lars Vatten; Inger Njølstad; Tomas Axelsson; Chu Chen; Gary Goodman; Matt Barnett; Melissa M Loomis; Jan Lubiñski; Joanna Matyjasik; Marcin Lener; Dorota Oszutowska; John Field; Triantafillos Liloglou; George Xinarianos; Adrian Cassidy; Paolo Vineis; Francoise Clavel-Chapelon; Domenico Palli; Rosario Tumino; Vittorio Krogh; Salvatore Panico; Carlos A González; José Ramón Quirós; Carmen Martínez; Carmen Navarro; Eva Ardanaz; Nerea Larrañaga; Kay Tee Kham; Timothy Key; H Bas Bueno-de-Mesquita; Petra Hm Peeters; Antonia Trichopoulou; Jakob Linseisen; Heiner Boeing; Göran Hallmans; Kim Overvad; Anne Tjønneland; Merethe Kumle; Elio Riboli; Diana Zelenika; Anne Boland; Marc Delepine; Mario Foglio; Doris Lechner; Fumihiko Matsuda; Helene Blanche; Ivo Gut; Simon Heath; Mark Lathrop; Paul Brennan
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

10.  Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.

Authors:  Thorunn Rafnar; Patrick Sulem; Simon N Stacey; Frank Geller; Julius Gudmundsson; Asgeir Sigurdsson; Margret Jakobsdottir; Hafdis Helgadottir; Steinunn Thorlacius; Katja K H Aben; Thorarinn Blöndal; Thorgeir E Thorgeirsson; Gudmar Thorleifsson; Kristleifur Kristjansson; Kristin Thorisdottir; Rafn Ragnarsson; Bardur Sigurgeirsson; Halla Skuladottir; Tomas Gudbjartsson; Helgi J Isaksson; Gudmundur V Einarsson; Kristrun R Benediktsdottir; Bjarni A Agnarsson; Karl Olafsson; Anna Salvarsdottir; Hjordis Bjarnason; Margret Asgeirsdottir; Kari T Kristinsson; Sigurborg Matthiasdottir; Steinunn G Sveinsdottir; Silvia Polidoro; Veronica Höiom; Rafael Botella-Estrada; Kari Hemminki; Peter Rudnai; D Timothy Bishop; Marcello Campagna; Eliane Kellen; Maurice P Zeegers; Petra de Verdier; Ana Ferrer; Dolores Isla; Maria Jesus Vidal; Raquel Andres; Berta Saez; Pablo Juberias; Javier Banzo; Sebastian Navarrete; Alejandro Tres; Donghui Kan; Annika Lindblom; Eugene Gurzau; Kvetoslava Koppova; Femmie de Vegt; Jack A Schalken; Henricus F M van der Heijden; Hans J Smit; René A Termeer; Egbert Oosterwijk; Onno van Hooij; Eduardo Nagore; Stefano Porru; Gunnar Steineck; Johan Hansson; Frank Buntinx; William J Catalona; Giuseppe Matullo; Paolo Vineis; Anne E Kiltie; José I Mayordomo; Rajiv Kumar; Lambertus A Kiemeney; Michael L Frigge; Thorvaldur Jonsson; Hafsteinn Saemundsson; Rosa B Barkardottir; Eirikur Jonsson; Steinn Jonsson; Jon H Olafsson; Jeffrey R Gulcher; Gisli Masson; Daniel F Gudbjartsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2009-01-18       Impact factor: 38.330

View more
  325 in total

1.  A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival.

Authors:  Jason A Willis; Sara H Olson; Irene Orlow; Semanti Mukherjee; Robert R McWilliams; Robert C Kurtz; Robert J Klein
Journal:  Clin Cancer Res       Date:  2012-06-04       Impact factor: 12.531

Review 2.  Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms.

Authors:  Paige M Bracci
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

3.  Genetic susceptibility to pancreatic cancer.

Authors:  Alison P Klein
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

4.  Diabetes and pancreatic cancer.

Authors:  Donghui Li
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

5.  Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk.

Authors:  Kathryn L Terry; Shelley S Tworoger; Allison F Vitonis; Jason Wong; Linda Titus-Ernstoff; Immaculata De Vivo; Daniel W Cramer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-01-20       Impact factor: 4.254

6.  Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants.

Authors:  Ju-Hyun Park; Mitchell H Gail; Clarice R Weinberg; Raymond J Carroll; Charles C Chung; Zhaoming Wang; Stephen J Chanock; Joseph F Fraumeni; Nilanjan Chatterjee
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-14       Impact factor: 11.205

Review 7.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

8.  New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts.

Authors:  Donghui Li; James L Abbruzzese
Journal:  Clin Cancer Res       Date:  2010-07-20       Impact factor: 12.531

9.  LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer.

Authors:  S Wang; Z Zou; X Luo; Y Mi; H Chang; D Xing
Journal:  Oncogene       Date:  2018-03-16       Impact factor: 9.867

10.  Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma.

Authors:  Ren Zhang; Xiaonan Chen; Shengjie Zhang; Xueyan Zhang; Tong Li; Zhicai Liu; Jinwu Wang; Wenqiao Zang; Yuanyuan Wang; Yuwen Du; Guoqiang Zhao
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.